InMed Pharmaceuticals (INM) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

INM InMed Pharmaceuticals

Watchlist

4.1500
-0.0500-1.19%

Trading Jan 24 15:20 ET

3.01MMarket Cap-0.54P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds
InMed PharmaceuticalsJan 22 00:00 ET
Why InMed Pharmaceuticals (INM) Stock Is Skyrocketing
BenzingaJan 21 10:24 ET
InMed Pharmaceuticals Shares Are Trading Higher After the Company Announced That INM-901 Reduced Alzheimer 'S-related Inflammation in a Preclinical Study.
BenzingaJan 21 08:18 ET
InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study
InMed PharmaceuticalsJan 21 00:00 ET
Express News | InMed Pharmaceuticals Inc Files for Offering of 3 Mln Common Shares by Selling Stockholder - SEC Filing
ReutersDec 23, 2024 17:18 ET
InMed Announces Results of 2024 Annual General Meeting
InMed PharmaceuticalsDec 18, 2024 00:00 ET

Comments

Jaguar8

Jan 22 06:32

NEWS

$InMed Pharmaceuticals (INM.US)$
InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds
InMed Pharmaceuticals (NASDAQ: INM)has been granted its first international Patent Cooperation Treaty (PCT) patent in Mexico for novel cannabinoid analog compounds. The patent, titled 'Cannabinoid analogs and methods for their preparation', has a 20-year term and covers therapeutic applications for pain, glaucoma, inflammatory disease, anxiety, and neurological conditionsincluding Parkinson...

frogoracletrading

Jan 21 08:09

$INM Support / Resistance Levels

Here are the areas to watch today after the large move up.
$InMed Pharmaceuticals (INM.US)$

Stock_Drift

Jan 21 07:45

1/21/25 Watchlist 🚨🚨🚨🚨🚨

$EON Resources (EONR.US)$ $Trio Petroleum (TPET.US)$ $Asset Entities (ASST.US)$ $InMed Pharmaceuticals (INM.US)$ $Helius Medical Technologies (HSDT.US)$
📊⚡️📊

Jaguar8

Jan 21 07:12

NEWS

$InMed Pharmaceuticals (INM.US)$
InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study
InMed Pharmaceuticals (NASDAQ: INM) has announced positive results from a long-term preclinical Alzheimer's Disease study of INM-901. The drug candidate demonstrated significant reductions in several neuroinflammation markers:
- Dose-dependent and statistically significant reduction in plasma pro-inflammatory cytokines (TNF...

Trytosaveabit

Jan 21 06:33

update

$InMed Pharmaceuticals (INM.US)$ InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study
newsfile· 2 mins ago
INM-901 significantly reduced pro-inflammatory cytokines associated with Alzheimer's
Statistically significant reduction in neurodegeneration marker, neurofilament light chain ('NfL')
mRNA profile showed a reduction of several key neuroinflammatory genes in the brain

Trending Stocks

Symbol Mini Chart % Chg

Meta Platforms